Walgreens July Sales Increase 8.0 Percent
August 05 2013 - 8:00AM
Business Wire
Walgreens (NYSE: WAG) (Nasdaq: WAG) had July sales of $6.03
billion, an increase of 8.0 percent from $5.59 billion for the same
month in fiscal 2012.
Total front-end sales increased 3.6 percent compared with the
same month in fiscal 2012, while comparable store front-end sales
increased 2.3 percent. Customer traffic in comparable stores
decreased 1.2 percent while basket size increased 3.5 percent.
Prescriptions filled at comparable stores increased by 9.5
percent in July and increased 7.3 percent on a calendar day-shift
adjusted basis. This year’s July had one additional Wednesday and
one fewer Sunday compared with July 2012. These calendar shifts
positively impacted prescriptions filled at comparable stores by
2.2 percentage points.
The company said the percentage of Express Scripts prescriptions
returning to its pharmacies continued to increase in July.
July pharmacy sales increased by 9.9 percent, while comparable
store pharmacy sales increased 8.8 percent and increased by a
calendar day-shift adjusted 6.6 percent. Calendar day shifts
positively impacted pharmacy sales in comparable stores by 2.2
percentage points. Calendar day-shift adjusted comparable store
pharmacy sales were negatively impacted by 2.8 percentage points
due to generic drug introductions in the last 12 months. Pharmacy
sales accounted for 64.6 percent of total sales for the month.
Sales in comparable stores increased by 6.3 percent in July.
Calendar day shifts positively impacted total comparable sales by
1.4 percentage points, while generic drug introductions in the last
12 months negatively impacted total comparable sales by 1.8
percentage points.
Registrations for Walgreens Balance® Rewards loyalty program,
which launched in September 2012, totaled 79 million through
July.
Calendar 2013 sales to date were $42.02 billion, an increase of
3.4 percent from $40.64 billion in 2012.
Fiscal 2013 year-to-date sales for the first 11 months were
$66.05 billion, up 0.4 percent from $65.79 billion in the
comparable period in fiscal 2012.
Walgreens opened nine stores during July, including one
relocation, and closed one.
On July 31, Walgreens operated 8,571 locations in all 50 states,
the District of Columbia, Puerto Rico and Guam. That includes 8,105
drugstores, 184 more than a year ago, including 67 net stores
acquired over the last 12 months. The company also operates
infusion and respiratory services facilities, specialty pharmacies
and mail service facilities. Its Take Care Health Systems
subsidiary manages more than 700 in-store convenient care clinics
and worksite health and wellness centers.
July Comparable Sales and Prescriptions Filled
Cough, Calendar Generics Cold, Flu
Actual
Shift
Impact
Impact
Impact
Total Comp Sales 6.3 % 1.4 % -1.8 % 0.0 % Comp Front
End 2.3 % - - - Comp Rx Sales 8.8 % 2.2 % -2.8 % 0.1 %
Comp Rx Scripts
9.5
%*
2.2 % - 0.2 %
* Includes +1.9 percentage points from patients filling more
90-day prescriptions
Please note: Sales numbers and the adjustments shown in the
table are preliminary, unaudited and subject to revision.
Comparable stores are defined as those drugstore locations open for
at least 12 consecutive months without closure for seven or more
consecutive days and without a major remodel or a natural disaster
in the past 12 months. Acquired operating locations and relocations
are not included as comparable stores for the first 12 months after
the acquisition or relocation.
Cautionary Note Regarding Forward-Looking Statements: Statements
in this release that are not historical are forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words such as
"expect," “likely,” "outlook," “forecast,” "would," "could,"
"should," “can,” “will,” "project," "intend," "plan," "goal,”
“target,” “continue," "sustain," “synergy,” "on track," "believe,"
"seek," "estimate," "anticipate," "may," “possible,” "assume," and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve
risks, assumptions and uncertainties, including, but not limited
to, those described in Item 1A (Risk Factors) of our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each
of which is incorporated herein by reference, and in other
documents that we file or furnish with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated or
anticipated by such forward-looking statements. Accordingly, you
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made. Except
to the extent required by law, Walgreens does not undertake, and
expressly disclaims, any duty or obligation to update publicly any
forward-looking statement after the date of this report, whether as
a result of new information, future events, changes in assumptions
or otherwise.
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Sep 2023 to Sep 2024